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The specific advantages of ion beams for application in tumor therapy are attributed to
their different macroscopic and microscopic energy deposition pattern as compared to
conventional photon radiation. On the macroscopic scale, the inverted dose profile with
a Bragg peak and small lateral scattering allow a better conformation of the dose to the
tumor. On the microscopic scale, the localized energy deposition around the trajectory
of the particles leads to an enhanced biological effectiveness, typically expressed in
terms of the relative biological effectiveness (RBE). Experimental investigations reveal
complex dependencies of RBE on many physical and biological parameters, as e.g.,
ion species, dose, position in the field and cell or tissue type. In order to complement
the experimental work, different approaches are used for the characterization of the
specific physical and biological properties of ion beams. In a set of two papers, which are
linked by activities within a European HORIZON 2020 project about nuclear science and
application (ENSAR2), we describe recent developments in two fields playing a key role
in characterizing the increased biological effectiveness. These comprise the biophysical
modeling of RBE and the microdosimetric measurements in complex radiation fields.
This first paper gives a brief introduction into these fields and then focuses on aspects of
biophysical modeling of RBE, specifically on semi-empirical approaches that are currently
used in treatment planning for ion beam therapy. It summarizes the status and recent
developments of the Local Effect Model (LEM) and its conceptual framework and shows
examples of model validation using recent experimental data. The model is compared
to other approaches, e.g., to the Microdosimetric-Kinetic Model (MKM), that builds the
bridge to the experimental microdosimetric work.
Keywords: relative biological effectiveness (RBE), biophysical modeling, ion beam therapy, microdosimetry,
heavy ion
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INTRODUCTION
The main motivation for the application of ion beams in
radiotherapy is their advantageous depth dose profile, allowing
maximizing the dose to the tumor by simultaneously sparing the
surrounding normal tissue as compared to conventional photon
radiation [1–3]. Whereas, all ion species share this macroscopic
property, in particular heavier ions like carbon ions show an
additional advantage with respect to their biological effectiveness.
They exhibit an increased biological effectiveness in particular
toward lower energies, i.e., in the region where they come to
rest when penetrating tissue (the so-called “Bragg peak”) [4–6].
This increased effectiveness is expressed in terms of the relative
biological effectiveness (RBE), which is defined by the doses
required to achieve a given survival level with photons and ion









A major determinant of the RBE is the linear energy transfer
(LET) of the ions, characterizing the energy released to the
material surrounding the ion trajectory per unit path length. The
LET of monoenergetic beams is represented by a single value
and increases with decreasing energy; this generally leads to a
corresponding increase of RBE toward the Bragg peak region.
In case of irradiation fields formed by particles of different
types and energies, LET is represented by a distribution.
However, in order to simplify the representation, typically
averaged LET values are considered. There are two frequently
applied ways of calculating the average LET, the track average
LETT and the dose average LETD [7], where the LETD in general
is more closely related to RBE than LETT values.
Regarding the biologic effects of radiation, the induced cell
killing is a frequently used endpoint to characterize RBE. If cell
survival S(D) after irradiation with dose D is described in terms
of the linear-quadratic model
S (D) = e−(αD+βD
2)
the changes of the parameters α and β after ion irradiation as
compared to photon irradiation are typically characterized by [8]:
αIon ≥ αPhoton
βIon ≤ βPhoton
The changes primarily reflect the increase of the linear term
α, i.e., the initial slope of the dose response curve. The impact
on the quadratic term is less pronounced and subject to
larger uncertainties. Overall, this results in more straightened
dose response curves for high-LET radiation as compared to
photon radiation.
For the dose prescription in ion beam therapy, the increased
effectiveness needs to be adequately taken into account. However,
although conceptually the definition of RBE is simple, it cannot
be represented by a single fixed number in extended radiation
fields, but actually depends in a complex way on several
physical and biological parameters. Based on in-vitro studies,
the fundamental RBE dependencies can be summarized as
follows [8–11]:
1. RBE rises with LET up to a certain maximum and drops
toward higher LET values.
2. The RBE(LET) curves are shifted toward higher LET values
with increasing particle charge, i.e., for heavier particles.
3. RBE decreases with increasing dose and thus decreasing
survival level.
4. RBE is higher for cells that are radioresistant against
conventional photon radiation as compared to cells that are
sensitive against photon radiation.
As a consequence of these relations, RBE values in typical
treatment fields for ion beam therapy will vary with position in
the target field and depend on the fractionation scheme used.
Therefore, there is no single number for conversion of absorbed
dose to RBE-weighted dose. To fully exploit the advantageous
properties of ion beams, the systematic dependencies of the RBE
have to be fully considered in treatment planning in ion beam
therapy, allowing taking advantage of the vast experience made
with conventional photon therapy.
Role of the Microscopic Energy Deposition
Pattern
Careful analysis of the above-mentioned systematic dependencies
of RBE clearly indicates that the increased effectiveness of
ion beams is largely determined by their specific microscopic
patterns of energy deposition: whereas photons deposit their
energy by releasing secondary electrons almost randomly
distributed within the irradiated volume, ions deposit their
energy extremely localized and concentrated along the trajectory
of the ion. Qualitatively, this localized higher energy density
is expected to lead to more severe biological damages, e.g.,
clustered DNA damages, which finally result in a higher cell
killing effect. The adequate characterization of the microscopic
energy deposition patterns is thus a prerequisite for the detailed
understanding of their biological effectiveness.
Although there is general agreement in the community about
the relevance of the microscopic energy deposition pattern, it
is less obvious at which spatial scales these patterns need to
be characterized. For example, assuming the DNA within the
cell nucleus to be a critical target for radiation damages points
to the relevance of the nm scale [12–14]. In addition, analysis
of the formation of radiation-induced chromosome aberrations
suggests also the micrometer scale as particularly relevant [15].
Finally, early experimental data showed that the cell nucleus
represents the gross sensitive target for most radiation effects
[16], which points out the potential role of the 10 µm-scale.
A recent combined experimental and modeling study further
supports the importance of the 10 um-scale [17]. At the same
time, this study revealed that the above mentioned three scales
are not necessarily exclusive and that the relative importance of
the different scales may strongly depend on the LET.
A wide range of experimental as well as theoretical approaches
have been developed and discussed in order to address these
aspects. Within a set of two papers, we discuss recent results
obtained in two related fields: experimental microdosimetry and
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biophysical modeling. In the following, we briefly introduce some
key aspects of both fields and in the main part of this manuscript
then focus on recent results obtained with a specific biophysical
model – the Local Effect Model.
Experimental Microdosimetry
Experimental microdosimetry aims at the accurate
characterization of the energy deposition pattern in micrometer
dimensions and particularly also their fluctuations and
distributions.Major developments of this field were implemented
in the framework of neutron therapy, since neutrons – as ion
beams – exhibit an increased effectiveness as compared to
conventional photon radiation.
The microdosimetric approach assumes that the quality of
the radiation action, namely the biological effect per unit of
absorbed dose, merely depends on the energy deposition within
micrometer-sized critical target sites within the cell nucleus, so
called single-event imparted-energy ε1. The ratio ε1/l, where l
is the biological site mean-chord length of trajectories passing
the site, is called lineal energy, y. Radiation fields as typical for
ion beam therapy are characterized by a spectrum of y-values,
and the distribution depends on the position in the radiation
field. The biological effect is expected to be proportional to the
dose delivered by each y-component of the spectrum, i.e., in
general d(y) is indicative of the biological effect. RBE values can
be obtained from the d(y)-spectrum by appropriate convolution
with a weighting function r(y) that represents the increased
effectiveness as a function of y [18]. A simplified exploitation
of microdosimetric measurements is using the mean of the d(y)






· dy, or the mean
corrected with a saturation function of y, which is called y∗
(ICRU 36).
Experimental measurements of microdosimetric spectra are
frequently obtained using gas filled detectors, which actually
have macroscopic sizes in the order of millimeter to centimeter.
However, information on the micrometer scale is obtained by
appropriate rescaling according to the different densities of
gas and water. First microdosimeters were gas proportional
counters made with tissue-equivalent plastic and filled with
tissue-equivalent gasmixtures and were thus called TEPC (tissue-
equivalent proportional-counter). TEPCs have a high detection
efficiency, since they can detect also few ionization events thanks
to the electron multiplication in the filling gas. However, they
cannot operate in very high-intensity radiation fields, as their
geometrical size is hardly < 1mm. More recently, also solid-state
detectors became available, made e.g., of silicon semiconductor
material or of synthetic diamond. They are actually characterized
by much smaller geometrical dimensions as compared to TEPCs;
their geometrical size can be as small as 1µm, making them
fit to operate also in very intense radiation fields. However, this
advantage has to be balanced with lower detection efficiency. The
aspects of experimental microdosimetry will be developed more
deeply in the second paper.
Biophysical Modeling
A thorough overview over the broad range of biophysical models
addressing the aspects of high-LET radiation, covering extremely
detailed so-called mechanistic models as well as semi-empirical
and empirical approaches would be beyond the scope of this
paper. We thus restrict here to some key aspects relevant for
two models actually used in ion beam therapy at present, the
Microdosimetric-Kinetic Model (MKM) [19, 20] and the Local
Effect Model (LEM) [21–23].
The transition from the initial energy deposition to the
final observable biological effect after a radiation insult includes
numerous complex biological processes and pathways, from
which many are still unknown or at least not yet accurately
quantified, and any model thus can represent an approximation
to reality only. One of the major challenges of modeling in the
framework of treatment planning therefore is to find the right
balance between accuracy and model complexity, i.e., number
of different processes and mechanisms to be taken into account
[24, 25].
Simplifications are made in both models typically with respect
to two aspects:
1. Details of the stochastic distribution of energy deposition
of ions around their trajectory on the level of individual
secondary electrons are neglected.
2. The details of the complex biological processes, like e.g.,
the DNA damage signaling and repair pathways, and the
corresponding uncertainties are “hidden” bymaking reference
to the known photon dose response curve in a type of “black
box” approach.
The models therefore do not aim at an ab-initio
calculation/prediction of the biological effects of ion beams
from first principles, but rather on a translation of what is
known from photon radiation to the specific aspects of the
microscopic energy deposition pattern of ion traversals through
the cell nucleus.
The models mainly differ with respect to the level of detail
on which the spatial distribution of energy deposition around
the particle trajectory is taken into account. Whereas, e.g.,
the MKM is strongly linked to the facets of the experimental
microdosimetry as described above and thus focuses on the
energy deposition features on the micrometer scale, the LEM
explicitly considers the impact of track structure on the
nanometer, the micrometer and the 10-micrometer level [17].
Link Between Both Fields
The two aspects described above approach the problem of
characterizing radiation quality from different directions and
are, in a way, complementary. Microdosimetry focuses on the
possibility to characterize experimentally the microcoscopic
energy deposition in any complex radiation field, as it is typical
for the superimposition of ion beams with different primary
energies as required to form a spread-out Bragg-peak (SOBP). It
is thus suitable to check radiation quality in typical patient plan
like dose distributions and thus for quality assurance issues.
The modeling approach in contrast also makes use of some
quantities and features of ion beam radiation, which cannot be
directly measured in complex radiation fields. Instead, models
make use of parametrizations, which are validated independently
in specific experiments also under conditions which might even
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be beyond typical patient treatment conditions, e.g., by using also
heavier ions than carbon or a larger energy regime. An advantage
of the modeling approach is that it facilitates taking into account
aspects of microscopic energy deposition on any spatial level,
and thus potentially allows a more accurate description of the
underlying mechanisms leading to the increased RBE.
BIOPHYSICAL MODELING: GENERAL
ASPECTS
In principle, protons as well as heavier ions exhibit an increased
RBE toward the end of their range when penetrating tissue.
However, the demand for RBE modeling for treatment planning
in ion beam therapy is clearly more relevant in the case of heavier
ions than for protons, since RBE values are substantially greater
for heavy ions. Nevertheless, it is still under discussion whether
a variable RBE instead of using a constant RBE = 1.1 could
be beneficial in proton therapy [26–29]. Nonetheless, numerous
simplified, empirical models have been proposed which are
applicable solely to the case of protons, as they are based on
certain simplified assumptions that are not valid for heavier
ions [30].
At present, two different models are used in treatment
planning for carbon-ion beam therapy: the Microdosimetric-
Kinetic Model (MKM) is used in the Japanese facilities, whereas
the Local EffectModel (LEM) is used in the European facilities. In
both approaches, the characterization of the microscopic energy
deposition pattern represents a major ingredient, although the
details how this energy deposition pattern is translated into
a biological response substantially differ. The characterization
of the dose response curve after low-LET radiation represents
the second pillar of these models. In the following, we briefly
introduce themain concepts of these models. Althoughmodeling
results are presented in the results section only for the LEM,
understanding the key aspects of the MKM is of relevance for
the discussion and with respect to its link to the experimental
microdosimetry approach presented in the second paper.
BASIC CONCEPTS OF MODELS
Local Effect Model
The LEM in its original version (LEM I; 21) is used for treatment
planning in the European carbon ion facilities. For this first
version of the model an accurate representation of the effects
of carbon ions was the major focus, and the application to
other ion species required corresponding adaptation of input
parameters. More recently improved versions of the model have
been developed, and the most recent version (LEM IV; [22, 23])
now allows the simultaneous consistent prediction of RBE over
a wide range of particles with similar accuracy based on a single
set of input parameters. The basic idea of the LEM is to predict
effects of high-LET radiation based on the known effects of low-
LET radiation in combination with the characterization of the
inhomogeneous, localized energy deposition pattern of charged
particles. The effect calculation within the LEM IV includes the
following major steps:
1. Characterization of the microscopic spatial energy deposition
pattern by means of an amorphous track structure approach.
This reflects the mean energy deposition (so called local dose)
as a function of the distance from the particle trajectory,
largely given by D(r)∼ 1/r2.
2. Determination of the spatial distribution of DSB of a single
particle traversal through the cell nucleus derived from the
amorphous track structure in combination with the known
DSB yield of 30 DSB/Gy/nucleus after photon irradiation.
Extremely high energy deposition in nanometer dimensions
within the center of particle tracks can lead to correspondingly
higher yields of DSB as compared to photon radiation by
increased clustering of SSB leading to additional DSB.
3. Characterization of the clustering properties of DSB with
respect to the giant loop substructure of the chromatin
organization, containing typically 2 Mbp DNA and
approximated by ∼0.5µm sized subvolumes of the nucleus.
Chromatin loops containing just a single DSB are called
isolated DSB (iDSB), chromatin loops with 2 or more DSB are
called clustered DSB (cDSB).
4. Determination of the trend to form clustered DSB, captured






5. Determination of the photon dose leading to the same
proportion of iDSB and cDSB, i.e., the same cluster index.
6. Calculation of the biological effect for this “iso-complexity”
photon dose according to a (modified) LQ-approach.
7. Determination of the effect of ion irradiation from the
effect of photons at the dose determined in the previous
step by appropriate rescaling of the photon effect according
to the total number of DSB induced by photon and ion
irradiation, respectively.
LEM IV has been demonstrated to accurately represent
experimental data in-vitro over a larger range of different ion
species from protons to oxygen ions [22, 31–33]. Furthermore,
besides in-vitro experiments also RBE for in-vivo experiments,
e.g., the tolerance of the rat spinal cord, can bemodeled with LEM
IV [34, 35]. Interestingly, the concept of damage classification
that has been developed for the LEM IV has been shown to
be applicable also to other radiation qualities, and several key
aspects like LQ-shape of survival curves, rejoining kinetics, dose
rate effects and cell cycle effects are consistently modeled by this
approach [36–38].
MKM
The MKM makes use of characterization of energy deposition
in micrometer-sized volumes and of concepts implemented in
the experimental microdosimetry branch. Its original version has
been developed by Hawkins [19, 20], and subsequent further
developments have been implemented in the framework of the
Japanese heavy ion therapy projects [39, 40].
The key variable on which the MKM is based is the lineal
energy y. However, predictions of the increased effectiveness
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do not use the details of the corresponding microdosimetric
spectrum, but rather it’s dose weighted mean value yD. The basic
assumption of theMKM is, that in a first approximation the shape
of the y-distribution can be ignored as long as the value of yD
is identical for different distributions. The essential dependence
reflecting the increased RBE in terms of the linear-quadratic
parameters is then given by [41]:









Here, αIon represents the linear term of the dose response
curve after ion irradiation, α0 the corresponding parameter for
radiation qualities with LET→0 and d the diameter of the critical
sensitive volume. The quantity β denotes the quadratic term of
the dose response curves, which is identical to the value for
photon radiation according to the MKM approach. Therefore,
only the α-term is affected by high-LET radiation as compared to
low-LET radiation. In a first approximation, α0 can be identified
with the α value obtained after photon reference radiation.
As Equation (2) describes a continuously increasing α with
increasing yD, it is not compatible with the drop of RBE toward
very high LET values which results from the overkill effect.
However, a saturation correction has been introduced [40] in
order to account for this effect. The correspondingly corrected
dose mean lineal energy is denoted by y∗, and replacing yD by
y∗ in Equation (2) then reflects the generally observed shape of
RBE(LET) curves.
Equation (2) also allows the direct link to experimental
microdosimetric measurements, from which yD can be obtained
[e.g., 38]. Simulated spectra can be used as well, using e.g.,
amorphous track structure approaches to derive yD values for the
use in conjunction with the MKM [42]. The MKM now serves as
a replacement for the former experimentally based approach to
characterize cellular RBE in-vitro within SOBPs in the Japanese
treatment planning approach.
Other Models
Apart from the LEM and the MKM, other approaches are
discussed for potential applications in ion beam therapy, as e.g.,
reported in [43–45]. However, a conceptual comparison of the
models has revealed substantial differences e.g., with respect to
the impact of overkill at very high LET and the change of the
quadratic component with LET (see e.g., [46]). This underlines
the need for a more detailed validation of the models by means
of experimental data in order to assess the impact of these model
differences on the accuracy of the model prediction.
RECENT RESULTS FOR LEM IV
In the following, we report about recent results obtained with
the LEM IV with respect to a broad range of applications,
comprising comparisons to experimental data in-vitro and in-
vivo. In addition, we illustrate the impact of specific concepts
underlying the LEM, highlighting the importance of different
spatial scales to explain the systematic dependencies of RBE.
COMPARISON TO EXPERIMENTAL DATA
AT INFN-LNS
Brief Description of Experimental
Conditions and Simulation With TRiP98
Irradiations of cell samples were performed in Istituto Nazionale
di Fisica Nucleare, Laboratori Nazionali del Sud (INFN – LNS),
Catania, Italy, with 62 MeV/u carbon ions at the 0◦ beam line
and with 62 MeV therapeutic protons at the CATANA (Centro
di AdroTerapia e Applicazioni Nucleari Avanzate) facility for
treatment of eye melanoma. Details of the experimental results
and the corresponding reference experiments using photon
radiation are given elsewhere [47, 48], and here we only
briefly report the main experimental conditions relevant for
this contribution.
Four different tumor cell lines (CRL5876, HTB140,
HTB177, MCF7) have been used, covering a broad range
of radiosensitivities. Proton irradiations were performed using
a 62 MeV proton beam in the center of a 15mm SOBP, located
at 10–25mm depth [47]. The corresponding LETD was 4.7
keV/µm. Carbon ion irradiations were performed with a
62 MeV/u beam for both a monoenergetic beam as well as
a small, about 2mm wide SOBP, which however does not
deliver a homogeneous dose [48]. Details of the corresponding
dose distributions are reported in Romano et al. [49] (see
also Figure 1). Irradiation of the cells with monoenergetic
beams was performed at the proximal side of the Bragg peak,
where ∼ 50% of the maximum relative dose are deposited
(corresponding to 7.6mm depth as marked in Figure 1 (left)
1; LET: 198 keV/µm). Irradiation under a very narrow, 2mm
SOBP condition was performed at the position where about
98% of the maximum relative dose are reached (corresponding
to 5.4mm as marked in Figure 1 (right); LET: 208 keV/µm).
To obtain reliable statistics all irradiations with protons and
carbon ions were performed in duplicate in three separate
experiments, except those carried out with the monoenergetic
carbon ions that were done in duplicate and repeated seven
times. The increased repetition of irradiations with pristine
carbon ions was necessary because of the delicate experimental
conditions (positioning of cell samples) caused by a very narrow
Bragg peak.
The corresponding depth-dose distributions were simulated
using the TRiP98 treatment planning environment [50, 51]
(Figure 1). Since this system had been developed for planning
under the conditions relevant for the GSI pilot project, i.e.,
base data are only available for beam energies >80 MeV/u,
some approximations had to be used in order to mimic the
conditions reflecting the INFN-LNS experiments. First, the
lower energies have been mimicked by artificially introducing
some bolus material in the treatment planning system. This,
however, is not expected to have a large impact on the predicted
RBE values, as the contribution of fragments is still low even
with the additional bolus material, and the primary C ions
will dominate the effectiveness. Therefore, as long as the dose
is simulated correctly, also predicted RBE values are close
to those expected in the “real” situation. Second, dose and
Frontiers in Physics | www.frontiersin.org 5 August 2020 | Volume 8 | Article 272
Scholz et al. Biophysical Modeling of RBE
FIGURE 1 | Depth dose distributions for monoenergetic (left) and SOBP (right) carbon ion irradiation according to TRiP calculations used in this paper as compared to
those reported by Romano et al. [49]. Irradiation positions are marked by arrows.
LET values are subject to uncertainties, which are particularly
relevant in the case of monoenergetic carbon-ion irradiation
conditions due to the pronounced dose and LET gradients
at this position in depth. We thus performed the model
calculations also for a variation of± 0.1mm around the planning
position of 7.6mm depth in order to get some feeling for
the corresponding uncertainties of survival curve predictions.
Practically, we simulated the error of ± 100µm in cell samples
positioning, based on the 50µm step width of the mechanical
device that was used for sample positioning. For the carbon ion
“SOBP” conditions depth dose profiles were simulated using a
2mm ripple filter [52], which results in a depth-dose profile
in reasonable agreement with the profile reported by Romano
et al. [49].
Comparison With LEM Predictions
The parameters listed in Table 1 have been used as input
for the LEM calculations [48]. For HTB140 cells, two
different sets, a and b, have been used for comparison,
since this cell line is characterized by an unusual, extreme
radiation resistance, and thus very high doses are required
to extract a reliable β-parameter. As experiments have
been performed with γ-rays over different dose ranges,
correspondingly different sets of LQ-parameters have been
obtained and are used for the LEM calculations for that
cell line.
Predicted survival curves for the different conditions are
shown in Figure 2 in comparison to the experimental data
[48]. Surviving fractions are presented as mean values ±
standard error of the mean of at least three (seven in the
case of monoenergetic carbon ions) separate experiments. In
general, standard error of the mean ranges from <5%, which
is the case for smaller doses, to somewhat more than 15%
for larger doses. This increase is the consequence of the
TABLE 1 | Photon input parameters for the LEM calculations shown in Figure 2.
Cell type α (Gy−1) β (Gy−2) α/β (Gy) Dt (Gy)
CRL5876 0.166 ± 0.059 0.042 ± 0.019 3.95 8.34
HTB140a [47] 0.036 ± 0.009 0.000 ± 0.000 inf 190
HTB140b [53] 0.0171 ± 0.0084 0.001 ± 0.0005 17.1 22.81
HTB177 0.120 ± 0.048 0.050 ± 0.016 2.4 6.64
MCF7 0.064 ± 0.176 0.057 ± 0.081 1.12 5.23
fact that as the number of survived cell colonies falls (with
the rise of dose) to 10−2 and further to 10−3 where there
are only a few colonies that are counted, thus the statistics
considerably deteriorates.
For protons, measured survival in general is lower than
predicted by the LEM.
For the monoenergetic carbon ions, as expected the
calculations are very sensitive to the exact depth position; for
all cell lines, the curves assuming a depth shift of −0.1mm
as compared to the desired position agree reasonably well
with the experimental data. Also, the curves for the SOBP
conditions show good agreement with the experimental data, and
as expected they are also much less sensitive to the exact position
in depth.
HTB140 cells are characterized by two special features:
an extremely low sensitivity and an almost linear photon
dose response curve. Model calculations have therefore been
performed with two different parameter sets HTB140a and
HTB140b (see Table 1), assuming either purely linear photon
dose response or a small β-term of 0.001 Gy−2 according to
Petrovic et al. [53]. As this latter parameter set better reflects
the photon dose response curve at higher doses, this dataset
also is expected to result in more accurate LEM predictions for
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FIGURE 2 | Comparison of LEMIV model calculations (lines) with experimental cell survival data (symbols) obtained at the INFN-LNS beamlines with different cell lines
and different radiation qualities. For details see text. Calculations for ± 0.1 and ± 0.15mm refer to potential positioning inaccuracies as compared to the desired depth.
high-LET radiation; the corresponding comparison is shown in
Figure 2. Although the detailed shape of the experimental dose
response curves is not predicted by the LEM, at least the order of
magnitude of the spread of sensitivities between photon and high
LET radiation is correctly predicted.
Contribution of Different Spatial Scales:
DSB-Clustering vs. Increased Yield
The direct comparison of LEM predictions for HTB140 cells
based on the two different data sets is shown in Figure 3. For
protons, no substantial difference is observed for the different
input data sets. In contrast, for carbon ion irradiation, the curves
significantly differ, but already for β = 0 a clearly increased RBE
is predicted. This can be attributed to the increased DSB yield
resulting from the extremely high local doses in the track center
of the particle trajectories, i.e., it is a consequence of processes at
the nm-scale. This increased yield is in line with predictions of
other models like e.g., PARTRAC [54].
In that respect, the LEM substantially differs from the MKM
which would predict RBE = 1 in the case of β = 0 according
to Equation (2). If a small β is assumed, as in the parameter set
HTB140b, according to the LEM the RBE is further increased,
which then can be attributed to the higher lethality of clustered
DSB as compared to isolated DSB. This higher lethality is a direct
consequence of β > 0 according to the LEM concept, reflecting
processes at the µm scale. In general, RBE is due to contributions
from multiple coexisting scales.
Use of Focused Low-LET Proton Beams to
Mimic High-LET
The role of the contribution on different spatial scales has
been further demonstrated recently using a special irradiation
technique based on focused low-LET proton beams [17]. The
basic idea of the experimental concept is to mimic high-
LET radiation by focusing low-LET radiation to a small spot
of about micrometer dimension, which reflects both the size
of important biological structures within the cell as well as
typical extensions of the radial dose distribution of high LET
light ions. The experiments demonstrated that for identical
average macroscopic doses, focused low-LET protons show a
substantially increased effectiveness as compared to conventional
broad beam irradiation. In the framework of the LEM concept,
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FIGURE 3 | Comparison of LEMIV model calculations for cell killing of HTB140
cells using two different input data sets (see Table 1). For carbon ions at high
LET, even in the case of βphoton = 0 Gy
−2 a substantially increased RBE is
predicted, which is further enhanced if βphoton > 0 is assumed.
this is attributed to the clustering of DSB within giant loop
chromatin compartments of about 0.5 µm size.
However, when comparing to e.g., carbon ions with the same
energy deposition per spot, protons are still less effective. This
difference arises from the extremely high local doses in the
track centers of carbon ions, which lead to additional DSBs.
Focusing low-LET protons to micrometer spots, however, is not
sufficient to reach these high local doses – it would require
to focus the protons on nm-sized spots, which is technically
not feasible.
In Figure 4 we show the LEM predictions of RBE for a
hypothetic cell line characterized by typical L-Q parameters for
the impact of spot size of low LET protons. The figure clearly
shows the transition to elevated RBE levels as soon as the spot
size is decreased below ∼1µm. The figure also includes the
information about the RBE that is expected for carbon ions for
the same mean dose (arrow); the difference between the carbon
ion and focused proton RBE values at small spot sizes is attributed
to the increased DSB yield of C-ions as compared to protons, as
explained above.
Validation in-vivo: Tolerance of the Rat
Spinal Cord to Proton Irradiation
Model validation based on in-vitro data as shown e.g. in section
Comparison to Experimental Data at INFN-LNS and in Figure 2
is an important first step in testing a model that is considered
for application in treatment planning for ion beam therapy. For
the close link to the patient treatments, however, the validation
by means of in-vivo experimental animal data is indispensable.
First tests of the LEM in such preclinical experiments have been
performed for carbon-ion irradiation of the skin of minipigs [55].
Larger systematic studies have then been performed based on
the analysis of tolerance doses for the rat spinal cord [35, 56].
These studies also clearly demonstrated the better accuracy of the
LEM IV as compared to the LEM I in particular in the critical
high-dose/high-LET region. In the entrance channel at low LET,
however, some systematic underestimation of the RBE by the
LEM IV is observed. In order to clarify whether this is a general
systematic effect at lower LET values or whether it is ion specific,
comparison to data obtained with proton beams is an important
pillar for the validation of the LEM.
Figure 5 shows a comparison of the LEM predictions with
experimental data reported by Saager et al. for irradiation in
typical therapy-like conditions, i.e., using a proton SOBP of
6 cm width located at 7–13 cm depth in water. RBE values were
determined at different positions within the SOBP, corresponding
to different LET values. LEM predictions are in reasonable
agreement with the experimental data, demonstrating that, in
general, the LEM IV allows RBE predictions also for lighter
ions with correspondingly lower LET, and thus the systematic
deviations found for carbon ions at low LET are specific for
carbon ions and likely are a consequence of the high energy rather
than the low LET itself.
Both experimental data and model predictions shown in
Figure 5 are in good agreement and support that also for protons
at the distal edge of the SOBP elevated RBE values are observed,
which are significantly above the RBE value of 1.1 that is currently
assumed in treatment planning for proton therapy. Here, it
has to be taken into account that the data were obtained for
comparably high doses in 1 fraction (Fx) acute and 2Fx split-
dose irradiations. Since the RBE is expected to further rise with
decreasing doses, we have included in Figure 5 also the LEM IV
prediction of RBE for the typical 2 Gy/Fx dose that is frequently
used in therapy. Substantially higher RBE values are expected
for these lower doses. Experiments with higher fraction number
and correspondingly lower doses are currently under way at the
Heidelberg ion beam therapy facility HIT, and the results will
represent an important data set to further validate the LEM for
application to proton irradiation.
Accuracy of LETD as Descriptor for RBE
Potentially increased RBE values in proton therapy which are
above the standard value of 1.1 that is currently used in
treatment planning [58] are under vivid debate now since many
years [26–28]. A wide range of models has been developed for
taking these increased RBE values into account. In contrast
to models like the MKM and LEM these models for proton
RBE are mostly empirical and parameterize the increase of
RBE as a function of LETD. Rorvik et al. have compared 13
of these models, demonstrating that even when starting from
identical conditions (i.e., assuming identical αX/βX-ratios for
photon radiation) for all models there is a wide spread in the
predicted RBE values. This might partially be because different
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sets of experimental data are used to calibrate the models.
One important aspect in that respect is the use of LETD as a
predictor of RBE. As we have recently shown, LETD values are not
necessarily a good predictor of RBE, and for conditions resulting
in the same LETD but based on different actual distributions
the expected RBE values might also substantially differ [59].
In order to illustrate this, Figure 6 shows RBE values along
a typical SOBP as predicted with the LEM in conjunction
with the TRiP98 treatment planning environment for protons
and carbon ions in comparison to monoenergetic beams with
identical LETD. For both particle types the SOBP values differ
from those expected for the corresponding monoenergetic beam
under track-segment conditions, although in opposite directions.
Whereas, for protons higher RBE values are expected in the case
of SOBP, for carbon ions these values are lower. This can be
explained by the non-linearities of the RBE(LET) relationship
under track-segment conditions [59]. The LET values relevant
for mixed SOBP fields in the proton case cover the LET
region to the left side of the RBE maximum, and thus the
non-linear increase of RBE with LET leads to correspondingly
higher weights of the high-LET contribution. In contrast, highest
LET values in the carbon case are linked to the LET region
to the right side of the RBE maximum, where RBE already
drops as a result of overkill effects. Therefore, the highest LET
components get an effectively lower weight in the energy/LET
spectra representative for typical carbon-ion treatment fields, and
LETD in general cannot be considered as a unique predictor
of RBE.
DISCUSSION
In Figure 2 we have demonstrated that the LEM is able to
predict the general features of RBE for different cell lines and
different radiation qualities. For monoenergetic carbon ions,
the predictions significantly depend on the assumed depth
position of the cell layer. Within the experimental uncertainties
of positioning (estimated to be in the order of +/– 0.1mm),
however, the model predictions agree with the experimental
data. Systematic underestimation of RBE has been observed
for protons for doses > 2Gy, whereas for doses ≤ 2Gy the
predicted effectiveness is still compatible with the experimental
data. Previous comparisons of the LEM predictions for protons
using a larger database have revealed mean deviations of <10%
in the LET range up to 8–10 keV/µm [31], although individual
experiments can show larger deviations similar to those seen
in Figure 2.
Concerning the different cell lines, largest deviations between
model prediction and experimental data are observed for the
extremely radioresistant cell line HTB140. The experimental data
indicate a trend to even negative bending of the dose response
curves; this trend is not reflected by the LEM, although the
order of magnitude of predicted RBE for the highest LET is
compatible with the experimental data. One possible explanation
for the somewhat unusual shape of the dose response curve
could be the composition of subpopulations with substantially
FIGURE 4 | Expected dependence of RBE for a hypothetic cell line on the
spot size of focused high-energy, low-LET protons at a mean dose of 1.0Gy.
For comparison, the RBE for broad beam carbon ion irradiation is shown.
Calculations are based on the LEM input parameters: αPhoton = 0.1 Gy
−1,
βPhoton = 0.05 Gy
−2, Dt = 8Gy, Ep = 19.95 MeV, LETp = 2.67 keV/µm, EC =
4.05 MeV/u, LETC = 338 keV/µm.
FIGURE 5 | Comparison of LEMIV based RBE predictions for tolerance doses
of the rat spinal cord in a 60mm proton SOBP ranging from 70 to 130mm
water-equivalent depths. Experimental data for 1Fx and 2Fx were taken from
[57], corresponding to TD50 values ranging from 21.7 to 19.5Gy for 1Fx and
from 32.3 to 27.9Gy for 2Fx irradiation. The full green line indicates the
expected RBE for lower doses of 2 Gy/Fx, as it is typically used in the
therapeutic situation.
different radiosensitivities, as it occurs e.g., also for mixed oxic
and hypoxic populations [60].
Concerning the general systematic dependencies, the results
shown in Figures 3, 4 clearly demonstrate the impact of
clustering effects on different spatial scales in the LEM; this aspect
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FIGURE 6 | Comparison of predicted RBE10 values for HTB177 cells along a 40mm proton SOBP (left) and carbon SOBP (right) from 80 to 120mm with RBE10
values expected for track segment conditions (i.e., monoenergetic beams) at the same dose mean LET. The dashed line in the left panel indicates the RBE of 1.1,
which is currently used in treatment planning for proton therapy.
is particularly relevant for comparison with other models. Since
apart from protons the LEM has been shown to also correctly
reflect the systematic dependencies for focused carbon ions and
lithium ions [17], which further supports the impact of clustering
on different spatial scales. The corresponding contributions as
a function of LET have been disentangled in more detail in
Friedrich et al. [17].
The experiments using focused low-LET proton beams to
mimic and explain high-LET effects represent an important
pillar for benchmarking effect models and in particular for the
validation of the LEM concept. However, although the LEM
obviously correctly predicts the fundamental dependencies of
RBE, its underlying concept is not necessarily the only possibility
to explain the increased effectiveness. It would thus be of
particular interest to compare also other models like the MKM
or Repair-Misrepair-Fixation (RMF) model to the focused ion
beam experiments and to analyze their predictive capacity for
these conditions.
Apart from cell killing after acute ion beam radiation, the
concept of damage clustering on the nm and µm level have
been successfully applied also to other radiation types like
high- and low-energy photon radiation [36, 61], to different
conditions like e.g., cell cycle dependence of radiosensitivity
[38] or the impact of dose rate [62] and to different end
points like e.g., rejoining of DSB [37, 63]. As also in these
cases in general good agreement between model predictions and
experimental data has been found, this is taken as further support
for the general concepts on which the LEM IV is based. The
independent applicability to multiple endpoints and radiation
phenomena within the same model framework using the same
model parameters is a strong indication for the validity of the
underlying mechanisms.
Modeling the effects of small focused beams might be
in general also relevant for novel applications of so-called
“spatially fractionated” irradiation like e.g., grid therapy. This
therapy is characterized by extremely inhomogeneous lateral
dose profiles, where peaks with very high doses are interlaced
with valleys of almost zero dose. Both low-LET photon and
proton irradiation as well as higher LET ion beam irradiation
have been proposed in that respect [64–67]. Although this
approach aims at reducing side effects in normal tissue by sparing
the valley regions, the complementary higher effectiveness that
is expected in the peak region will be relevant for a full
characterization of this application. A general understanding of
the impact on the biological effectiveness is thus of importance,
but will presumably also require including geometrical properties
of tissue repair processes that are not included in any RBE
radiation effect model nor in any normal tissue complication
model so far. This also requires correct modeling of in-vivo
experimental systems that are frequently used to investigate the
effectiveness of grid therapy [66]. An accurate prediction of
biological effects in-vivo using standard broad beam irradiation
is therefore a prerequisite for applications to more complex
scenarios like grid therapy. Whereas, effects in the SOBP region
of carbon ions are predicted by the LEM IV with reasonable
accuracy, there is a trend to systematic underestimation of
RBE in the entrance channel, i.e., at high energies [35].
Systematic comparison with larger data bases for in-vitro
cell kill studies are currently ongoing in order to accurately
quantify these deviations and to implement corresponding
model improvements.
The correct representation of RBE also in the case of
mixed fields, as they typically occur in the patient treatment
situation, is of utmost importance in treatment planning.
As shown in Figure 6, details of the energy/LET/particle
spectrum can affect the RBE predicted by the LEM when
compared to the corresponding mean values or single values
representing track segment conditions. In that respect, it
would be highly interesting to further investigate potential
differences that would result from the corresponding
microdosimetric concepts. For example, the approach using
weighting functions makes use of the detailed y-spectrum,
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whereas the MKM uses the corresponding dose-mean
y-values. Since y essentially represents a 1-dimensional
representation of track structure, similar to LET, one would
expect here also similar differences as observed in the case
of dose-mean LET. A direct comparison and analysis of
potential differences between these two approaches could shed
light on the impact of the shape of distributions from the
microdosimetric perspective.
OUTLOOK
Comparing the two approaches used in the current and the
accompanying paper, the major difference is that the modeling
approach explicitly considers different spatial scales, whereas the
microdosimetric approach focuses on aspects of the micrometer
scale. It will thus be of major interest to further analyse
the impact and relevance of the different scales for different
irradiation scenarios. It would be particularly helpful to use the
different approaches to develop hypothesis and specific scenarios
that allow discriminating between the different aspects. In that
respect, extension / translation of the microdosimetric concepts
to the nanometer scale as described e.g., by Grosswendt [68],
Selva et al. [69], and Mazzucconi et al. [70] are of further interest
for a comparison with the LEM approach.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
AUTHOR CONTRIBUTIONS
MS drafted the manuscript. MS and TF performed the
LEM calculations. AR-F and IP supplied the experimental
data obtained at the INFN-LNS facility and all relevant
information for the model comparison. GM and PC
contributed to the microdosimetry aspects. All authors
contributed to improvements/corrections and approved the
final version.
FUNDING
This work was supported by the European HORIZON 2020
ENSAR2 project, GRANT AGREEMENT NUMBER: 654002.
REFERENCES
1. Wilson RR. Radiological use of fast protons. Radiology. (1946) 47:487–
91. doi: 10.1148/47.5.487
2. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier
ion beams. J Clin Oncol. (2007) 25:953–64. doi: 10.1200/JCO.2006.09.7816
3. Schardt D, Elsässer T, Schulz-Ertner D. Heavy-ion tumor therapy:
Physical and radiobiological benefits. Rev Mod Phys. (2010) 82:383–
425. doi: 10.1103/RevModPhys.82.383
4. Blakely EA, Tobias CA, Yang TC, Smith KC, Lyman JT. Inactivation of human
kidney cells by high-energy monoenergetic heavy-ion beams. Radiat Res.
(1979) 80:122–60. doi: 10.2307/3575121
5. Tobias CA, Blakely EA, Alpen EL, Castro JR, Ainsworth EJ, Curtis SB, et al.
Molecular and cellular radiobiology of heavy ions. Int J Radiat Oncol Biol Phys.
(1982) 8:2109–20. doi: 10.1016/0360-3016(82)90554-5
6. Kraft G. Tumor therapy with heavy charged particles. Prog Part Nucl Phys.
(2000) 45:S473–544. doi: 10.1016/S0146-6410(00)00112-5
7. ICRU Report No. 36: Microdosimetry. J Int Commis Radiat Units Measure.
(1983) 19:1–120.
8. Friedrich T, Scholz U, Elsässer T, Durante M, Scholz M. Systematic analysis of
RBE and related quantities using a database of cell survival experiments with
ion beam irradiation. J Radiat Res. (2013) 54:494–514. doi: 10.1093/jrr/rrs114
9. Tobias CA, Blakely EA, Chang PY, Lommel L, Roots R. Response of sensitive
human ataxia and resistant T-1 cell lines to accelerated heavy ions. Br J Cancer
Suppl. (1984) 6:175–85. doi: 10.2172/7005318
10. Weyrather WK, Ritter S, Scholz M, Kraft G. RBE for carbon track-segment
irradiation in cell lines of differing repair capacity. Int J Radiat Biol. (1999)
75:1357–64. doi: 10.1080/095530099139232
11. Furusawa Y, Fukutsu K, Aoki M, Itsukaichi H, Eguchi-Kasai K, Ohara H,
et al. Inactivation of aerobic and hypoxic cells from three different cell lines
by accelerated (3)He-, (12)C- and (20)Ne-ion beams. Radiat Res. (2000)
154:485–96. doi: 10.1667/0033-758720001540485:IOAAHC2.0.CO;2
12. Ward JF. Mechanisms of DNA repair and their potential
modification for radiotherapy. Int J Radiat Oncol Biol Phys. (1986)
12:1027–32. doi: 10.1016/0360-30168690220-8
13. Nikjoo H, Uehara S, Wilson WE, Hoshi M, Goodhead DT. Track structure in
radiation biology: theory and applications. Int J Radiat Biol. (1998) 73:355–
64. doi: 10.1080/095530098142176
14. Goodhead DT. Initial events in the cellular effects of ionizing
radiations: clustered damage in DNA. Int J Radiat Biol. (1994)
65:7–17. doi: 10.1080/09553009414550021
15. Neary GJ, Preston RJ, Savage JR. Chromosome aberrations and the theory of
RBE. 3. Evidence from experiments with soft x-rays, and a consideration of
the effects of hard x-rays. Int J Radiat Biol Relat Stud Phys Chem Med. (1967)
12:317–45. doi: 10.1080/09553006714550881
16. Munro TR. The relative radiosensitivity of the nucleus and
cytoplasm of Chinese hamster fibroblasts. Radiat Res. (1970)
42:451–70. doi: 10.2307/3572962
17. Friedrich T, Ilicic K, Greubel C, Girst S, Reindl J, Sammer
M, et al. DNA damage interactions on both nanometer and
micrometer scale determine overall cellular damage. Sci Rep. (2018)
8:16063. doi: 10.1038/s41598-018-34323-9
18. Wambersie A, Hendry JH, Andreo P, DeLuca PM, Gahbauer R, Menzel H,
et al. The RBE issues in ionbeam therapy: conclusions of a joint IAEA/ICRU
working group regarding quantities and units. Radiat Prot Dosimetry. (2006)
122:463–70. doi: 10.1093/rpd/ncl447
19. Hawkins RB. A microdosimetric-kinetic model of cell death from
exposure to ionizing radiation of any LET, with experimental and clinical
applications. Int J Radiat Biol. (1996) 69:739–55. doi: 10.1080/0955300961
45481
20. Hawkins RB. A microdosimetric-kinetic model for the effect of non-poisson
distribution of lethal lesions on the variation of RBE with LET. Radiat Res.
(2003) 160:61–9. doi: 10.1667/RR3010
21. Scholz M, Kellerer AM, Kraft-Weyrather W, Kraft G. Computation of cell
survival in heavy ion beams for therapy. The model and its approximation.
Radiat Environ Biophys. (1997) 36:59–66. doi: 10.1007/s0041100
50055
22. Elsässer T, Weyrather WK, Friedrich T, Durante M, Iancu G, Krämer M,
et al. Quantification of the relative biological effectiveness for ion beam
radiotherapy: direct experimental comparison of proton and carbon ion
beams and a novel approach for treatment planning. Int J Radiat Oncol Biol
Phys. (2010) 78:1177–83. doi: 10.1016/j.ijrobp.2010.05.014
23. Friedrich T, Scholz U, Elsässer T, Durante M, Scholz M. Calculation
of the biological effects of ion beams based on the microscopic
spatial damage distribution pattern. Int J Radiat Biol. (2012)
88:103–7. doi: 10.3109/09553002.2011.611213
Frontiers in Physics | www.frontiersin.org 11 August 2020 | Volume 8 | Article 272
Scholz et al. Biophysical Modeling of RBE
24. van der Schaaf A, Langendijk JA, Fiorino C, Rancati T. Embracing
phenomenological approaches to normal tissue complication probability
modeling: a question of method. Int J Radiat Oncol Biol Phys. (2015) 91:468–
71. doi: 10.1016/j.ijrobp.2014.10.017
25. Olsen CH, Ottesen JT, Smith RC, Olufsen MS. Parameter subset selection
techniques for problems in mathematical biology. Biol Cybern. (2019)
113:121–38. doi: 10.1007/s00422-018-0784-8
26. Paganetti H. Relative biological effectiveness (RBE) values for
proton beam therapy. Variations as a function of biological
endpoint, dose, and linear energy transfer. Phys Med Biol. (2014)
59:R419–72. doi: 10.1088/0031-9155/59/22/R419
27. Peeler CR, Mirkovic D, Titt U, Blanchard P, Gunther JR, Mahajan A,
et al. Clinical evidence of variable proton biological effectiveness in
pediatric patients treated for ependymoma. Radiother Oncol. (2016) 121:395–
401. doi: 10.1016/j.radonc.2016.11.001
28. Jones B. Why RBEmust be a variable and not a constant in proton therapy. Br
J Radiol. (2016) 89:20160116. doi: 10.1259/bjr.20160116
29. Gensheimer MF, Yock TI, Liebsch NJ, Sharp GC, Paganetti H, Madan N, et al.
In vivo proton beam range verification using spine MRI changes. Int J Radiat
Oncol Biol Phys. (2010) 78:268–75. doi: 10.1016/j.ijrobp.2009.11.060
30. Rørvik E, Fjæra LF, Dahle TJ, Dale JE, Engeseth GM, Stokkevåg CH, et al.
Exploration and application of phenomenological RBE models for proton
therapy. Phys Med Biol. (2018) 63:185013. doi: 10.1088/1361-6560/aad9db
31. Grün R, Friedrich T, Krämer M, Scholz M. Systematics of relative biological
effectiveness measurements for proton radiation along the spread out Bragg
peak: experimental validation of the local effect model. Phys Med Biol. (2017)
62:890–908. doi: 10.1088/1361-6560/62/3/890
32. Krämer M, Scifoni E, Schuy C, Rovituso M, Tinganelli W, Maier A, et al.
Helium ions for radiotherapy? Physical and biological verifications of a novel
treatment modality.Med Phys. (2016) 43:1995. doi: 10.1118/1.4944593
33. Sokol O, Scifoni E, Tinganelli W, Kraft-Weyrather W, Wiedemann J,
Maier A, et al. Oxygen beams for therapy: advanced biological treatment
planning and experimental verification. Phys Med Biol. (2017) 62:7798–
813. doi: 10.1088/1361-6560/aa88a0
34. Saager M, Glowa C, Peschke P, Brons S, Scholz M, Huber PE, et al. Carbon
ion irradiation of the rat spinal cord: dependence of the relative biological
effectiveness on linear energy transfer. Int J Radiat Oncol Biol Phys. (2014)
90:63–70. doi: 10.1016/j.ijrobp.2014.05.008
35. Saager M, Glowa C, Peschke P, Brons S, Grün R, Scholz M, et al. Fractionated
carbon ion irradiations of the rat spinal cord: comparison of the relative
biological effectiveness with predictions of the local effect model. Radiat
Oncol. (2020) 15:6. doi: 10.1186/s13014-019-1439-1
36. Friedrich T, Durante M, Scholz M. Modeling cell survival after photon
irradiation based on double-strand break clustering in megabase pair
chromatin loops. Radiat Res. (2012) 178:385–94. doi: 10.1667/RR2964.1
37. Tommasino F, Friedrich T, Scholz U, Taucher-Scholz G, DuranteM, Scholz M.
A DNA double-strand break kinetic rejoining model based on the local effect
model. Radiat Res. (2013) 180:524–38. doi: 10.1667/RR13389.1
38. Hufnagl A, Herr L, Friedrich T, Durante M, Taucher-Scholz G, Scholz
M. The link between cell-cycle dependent radiosensitivity and repair
pathways: a model based on the local, sister-chromatid conformation
dependent switch between NHEJ and HR. DNA Repair. (2015) 27:28–
39. doi: 10.1016/j.dnarep.2015.01.002
39. Kase Y, Kanai T, Matsumoto Y, Furusawa Y, Okamoto H, Asaba T, et al.
Microdosimetric measurements and estimation of human cell survival for
heavy-ion beams. Radiat Res. (2006) 166:629–38. doi: 10.1667/RR0536.1
40. Inaniwa T, Furukawa T, Kase Y, Matsufuji N, Toshito T, Matsumoto
Y, et al. Treatment planning for a scanned carbon beam with a
modified microdosimetric kinetic model. Phys Med Biol. (2010) 55:6721–
37. doi: 10.1088/0031-9155/55/22/008
41. Hawkins RB. The relationship between the sensitivity of cells
to high-energy photons and the RBE of particle radiation used
in radiotherapy. Radiat Res. (2009) 17:761–76. doi: 10.1667/RR
1655.1
42. Kase Y, Kanai T, Matsufuji N, Furusawa Y, Elsässer T, Scholz M.
Biophysical calculation of cell survival probabilities using amorphous track
structure models for heavy-ion irradiation. Phys Med Biol. (2008) 53:37–
59. doi: 10.1088/0031-9155/53/1/003
43. Waligórski MP, Hollmark M, Gudowska I, Lesia J. Cellular parameters
and RBE-LET dependences for modelling heavy-ion radiotherapy.
Radiother Oncol. (2004) 73(Suppl. 2):S173–5. doi: 10.1016/S0167-8140048
0043-4
44. Frese MC, Yu VK, Stewart RD, Carlson DJ. A mechanism-based approach
to predict the relative biological effectiveness of protons and carbon
ions in radiation therapy. Int J Radiat Oncol Biol Phys. (2012) 8:442–
50. doi: 10.1016/j.ijrobp.2011.06.1983
45. Kamp F, Cabal G, Mairani A, Parodi K, Wilkens JJ, Carlson DJ. Fast biological
modeling for voxel-based heavy ion treatment planning using the mechanistic
repair-misrepair-fixation model and nuclear fragment spectra. Int J Radiat
Oncol Biol Phys. (2015) 93:557–68. doi: 10.1016/j.ijrobp.2015.07.2264
46. Stewart RD, Carlson DJ, Butkus MP, Hawkins R, Friedrich T, Scholz M. A
comparison of mechanism-inspired models for particle relative biological
effectiveness (RBE).Med Phys. (2018) 45:e925–52. doi: 10.1002/mp.13207
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